Pediatric Status Asthmaticus Clinical Presentation
- Author: Adam J Schwarz, MD; Chief Editor: Michael R Bye, MD more...
History
When obtaining the history from a child presenting with an acute exacerbation of asthma, the following should be determined:
- Presence of current illness, such as upper respiratory tract infection or pneumonia
- History of chronic respiratory diseases (eg, bronchopulmonary dysplasia, chronic lung disease of infancy)
- Severe previous respiratory syncytial virus (RSV) disease
- History of atopy
- History of allergies
- Family history of asthma
- Presence of pets or smokers in the home
- Known triggering factors
- Home medications (Obtain a detailed list of medications being taken at home and, if possible, the timing and dosage of medications)
- Risk factors for developing severe or persistent status asthmaticus
- History of increased use of home bronchodilator treatment without improvement or effect
- History of previous ICU admissions, with or without intubation
- Asthma exacerbation despite recent or current use of corticosteroids
- Frequent emergency department (ED) visits and/or hospitalization (implies poor control)
- Less than 10% improvement in peak expiratory flow rate (PEFR) from baseline despite treatment
- History of syncope or seizures during acute exacerbation
- Oxygen saturation below 92% despite supplemental oxygen
- Whether the patient has a severe asthma exacerbation without wheezing (ie, the silent chest): Such patients may have such severe airway obstruction or be fatigued so that he or she is unable to generate enough airflow to wheeze. This is an ominous sign of impending respiratory failure.
Physical
Immediately determine patient's condition and risk for respiratory failure at initial assessment. The acute episode of asthma may begin with mild symptoms of dyspnea. As the degree of airway obstruction worsens, respiratory distress, including retractions, use of abdominal muscles in exhalation, and inability to speak more than one or two words at a time, may all be observed. V/Q mismatch results in decreased oxygen saturation and hypoxia. Vital signs may show tachycardia and hypertension. The peak flow rate should be included in the vital signs in children who are able to cooperate and who are able to tolerate the peak flow maneuver without significant distress. Level of consciousness may progress from lethargy to agitation from air hunger and even syncope and seizures. If untreated, prolonged airway obstruction and marked increase in work of breathing may eventually lead to bradycardia, hypoventilation, and even cardiorespiratory arrest.
- General examination
- In the early stage of acute asthma exacerbation, slight tachycardia and tachypnea may be observed. As the episode progresses, tachycardia and tachypnea may worsen. Blood pressure may be elevated. The peak flow rate is a standard measure of airflow obstruction and is relatively simple to perform. Most patients with more than a mild exacerbation of asthma have hypoxia and decreased oxygen saturation due to V/Q mismatch. Some patients prefer to remain seated and leaning forward, rather than assuming a supine position. Use of accessory muscles has been shown to correlate with severity of airflow obstruction. An abnormally prolonged expiratory phase with audible wheezing can be observed.
- Children with status asthmaticus may appear dehydrated as a result of poor intake, vomiting, and increased work of breathing.
- Retractions (ie, intercostal, subcostal, use of abdominal muscles) may be observed.
- The use of accessory muscles correlates to severity of disease.
- Patients with moderate-to-severe asthma are often unable to speak in full sentences.
- Cardiovascular symptoms may include tachycardia or hypertension in mild-to-moderate asthma. With worsening hypoxemia, hypercarbia, marked air trapping, and hyperinflation, stroke volume is compromised and hypotension and bradycardia may be observed.
- CNS status ranges from wide-awake to lethargic, agitated to comatose. As hypoxemia progresses, lethargy progresses to agitation caused by air hunger. As more lung units become obstructed, hypoxemia worsens and hypercarbia develops. Both hypoxemia and hypercarbia can lead to seizures and coma and are late signs of respiratory compromise.
- Examination of the respiratory system
- Wheezing occurs from air moving through narrowed obstructed airways. This exhalation results in turbulent airflow and produces wheezes. Although asthma is the most common cause of wheezing, anything that causes airway obstruction and narrowing that results in turbulent airflow may generate wheezes. Therefore, not all wheezing is asthma. Other causes of wheezing may include the following:
- Viral infections/bronchiolitis: Common respiratory viral infections, such as RSV, may cause airway swelling and narrowing in infants and children, causing inflammation and swelling of the bronchioles and resulting in bronchiolitis. Although viral infections may clearly trigger asthma, typical bronchiolitis results from airway swelling and edema, not from bronchospasm, and is generally unresponsive to treatment with bronchodilators.
- Foreign body: Aspiration of a foreign body is a particularly important consideration in toddlers. These episodes are generally unwitnessed. When the foreign body lodges in the right or left mainstem bronchus or beyond, the child may present with a cough and wheezing, often unilaterally. When suspected, a chest radiograph should be obtained.
- Cystic fibrosis: Airways are obstructed with thick inspissated secretions.
- Extrinsic compression: Airways can be compressed from vascular structures, such as vascular rings, lymphadenopathy, or tumors.
- Congestive heart failure (CHF): Airway edema may cause wheezing in CHF. In addition, vascular compression may compress the airways during systole with cardiac ejection, resulting in a pulsatile wheeze that corresponds to the heart rate. This is sometimes erroneously referred to as cardiac asthma.
- Tracheomalacia: Although the airway sounds are slightly different from those of asthma, they are often referred to as wheezes.
- Auscultation often reveals bilateral expiratory and possibly inspiratory wheezes and crackles; air entry may or may not be diminished or absent, depending on severity. Remember, the silent chest may herald impending respiratory failure in a patient too obstructed or fatigued to generate wheezing.
- If tension pneumothorax develops, signs of tracheal deviation to the opposite side, decreased or absent air entry on the affected side, shift of the location of heart sounds, and hypotension may be evident. Air leaks may also include pneumomediastinum and subcutaneous emphysema.
- In moderate-to-severe status asthmaticus, abdominal muscle use can cause symptoms of abdominal pain.
- Pulsus paradoxus is a decrease in the systolic blood pressure during inspiration. It results from a decrease in cardiac stroke volume with inspiration due to greatly increased left-ventricular afterload generated by the dramatic increase in negative intrapleural and transmural pressure in a patient struggling to breathe against significant airways obstruction. Pulsus paradoxus greater than 20 mm Hg correlates well with the presence of severe airways obstruction (ie, forced expiratory volume in 1 second [FEV 1 ] < 60% predicted).
- Wheezing occurs from air moving through narrowed obstructed airways. This exhalation results in turbulent airflow and produces wheezes. Although asthma is the most common cause of wheezing, anything that causes airway obstruction and narrowing that results in turbulent airflow may generate wheezes. Therefore, not all wheezing is asthma. Other causes of wheezing may include the following:
Causes
Asthma results from a number of factors, including genetic predisposition and environmental factors.
- Inhaled allergens
- Patients often have a history of atopy.
- The severity of asthma has been correlated with the number of positive skin test results.
- Viral infections
- Air pollutants (eg, dust, cigarette smoke, industrial pollutants)
- Medications, such as beta-blockers, aspirin, and nonsteroidal anti-inflammatory drugs (NSAIDs)
- Gastroesophageal reflux disease
- Studies indicate that reflux of gastric contents with or without aspiration can trigger asthma in susceptible children and adults.
- Animal studies have shown that the instillation of even minute amounts of acid into the distal esophagus can result in marked increases in intrathoracic pressure and airway resistance. This response is thought to be due to vagal and sympathetic neural responses.
- Cold temperature
- Exercise
Gorelick M, Scribano PV, Stevens MW, Schultz T, Shults J. Predicting need for hospitalization in acute pediatric asthma. Pediatr Emerg Care. Nov 2008;24(11):735-44. [Medline].
National Asthma Education and Prevention Program (NAEPP) Expert Panel. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. 2007. National Heart, Lung, and Blood Institute; August 28, 2007. [Full Text].
[Best Evidence] Andrews T, McGintee E, Mittal MK, et al. High-dose continuous nebulized levalbuterol for pediatric status asthmaticus: a randomized trial. J Pediatr. Aug 2009;155(2):205-10.e1. [Medline].
[Best Evidence] Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics. Mar 2009;123(3):e519-25. [Medline].
Ciarallo L, Brousseau D, Reinert S. Higher-dose intravenous magnesium therapy for children with moderate to severeacute asthma. Arch Pediatr Adolesc Med. Oct 2000;154(10):979-83. [Medline].
Stephanopoulos DE, Monge R, Schell KH, et al. Continuous intravenous terbutaline for pediatric status asthmaticus. Crit Care Med. Oct 1998;26(10):1744-8. [Medline].
Chiang VW, Burns JP, Rifai N, Lipshultz SE, Adams MJ, Weiner DL. Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: a prospective assessment. J Pediatr. Jul 2000;137(1):73-7. [Medline].
Kalyanaraman M, Bhalala U, Leoncio M. Serial cardiac troponin concentrations as marker of cardiac toxicity in children with status asthmaticus treated with intravenous terbutaline. Pediatr Emerg Care. Oct 2011;27(10):933-6. [Medline].
Ream RS, Loftis LL, Albers GM, et al. Efficacy of IV theophylline in children with severe status asthmaticus. Chest. May 2001;119(5):1480-8. [Medline]. [Full Text].
Wheeler DS, Jacobs BR, Kenreigh CA, et al. Theophylline versus terbutaline in treating critically ill children with statusasthmaticus: a prospective, randomized, controlled trial. Pediatr Crit Care Med. Mar 2005;6(2):142-7. [Medline].
[Best Evidence] Kim IK, Phrampus E, Venkataraman S, Pitetti R, Saville A, Corcoran T. Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. Pediatrics. Nov 2005;116(5):1127-33. [Medline].
Kudukis TM, Manthous CA, Schmidt GA, Hall JB, Wylam ME. Inhaled helium-oxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children. J Pediatr. Feb 1997;130(2):217-24. [Medline].
Anderson M, Svartengren M, Bylin G, Philipson K, Camner P. Deposition in asthmatics of particles inhaled in air or in helium-oxygen. Am Rev Respir Dis. Mar 1993;147(3):524-8. [Medline].
Hebbar KB, Petrillo-Albarano T, Coto-Puckett W, et al. Experience with use of extracorporeal life support for severe refractory status asthmaticus in children. Crit Care. Mar 2 2009;13(2):R29. [Medline].
Elias JA, Zhu Z, Chupp G, Homer RJ. Airway remodeling in asthma. J Clin Invest. Oct 1999;104(8):1001-6. [Medline]. [Full Text].
Pearlman DS. Pathophysiology of the inflammatory response. J Allergy Clin Immunol. Oct 1999;104(4 Pt 1):S132-7. [Medline].
Asthma. In: Fuhrman B, Zimmerman J, eds. Pediatric Critical Care. 2nd ed. St. Louis, MO: Mosby; 1998:473-5.
Scarfone RJ, Loiselle JM, Joffe MD, et al. A randomized trial of magnesium in the emergency department treatment of childrenwith asthma. Ann Emerg Med. Dec 2000;36(6):572-8. [Medline].
Schuh S, Johnson DW, Callahan S, et al. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dosealbuterol therapy in severe childhood asthma. J Pediatr. Apr 1995;126(4):639-45. [Medline].
Schwarz AJ, Lubinsky PS. Acute severe asthma. In: Levin DL, Morriss FC, eds. Essentials of Pediatric Intensive Care. Vol 1. 2nd ed. 1997:143-56.
Werner HA. Status asthmaticus in children: a review. Chest. Jun 2001;119(6):1913-29. [Medline]. [Full Text].
Yung M, South M. Randomised controlled trial of aminophylline for severe acute asthma. Arch Dis Child. Nov 1998;79(5):405-10. [Medline]. [Full Text].
Zorc JJ, Pusic MV, Ogborn CJ, et al. Ipratropium bromide added to asthma treatment in the pediatric emergency department. Pediatrics. Apr 1999;103(4 Pt 1):748-52. [Medline]. [Full Text].

